FDA product code CKH: Acid Phosphatase, Beta Glycerophosphate

CKH is the FDA product code for acid phosphatase, beta glycerophosphate. It is a Class II device, regulated under 21 CFR 862.1020 and reviewed by the Clinical Chemistry panel. Devices under CKH reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it. FDA has posted 1 recall for CKH devices.

Classification

FieldValue
Device nameAcid Phosphatase, Beta Glycerophosphate
Device classClass II
Regulation21 CFR 862.1020
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k) exempt

Recalls for CKH devices

1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2004-08-20.

Frequently asked questions

What is FDA product code CKH?

CKH is the FDA product code for acid phosphatase, beta glycerophosphate. It is a Class II device, regulated under 21 CFR 862.1020 and reviewed by the Clinical Chemistry panel.

What device class is CKH?

Class II, regulation 21 CFR 862.1020. Typical premarket route: 510(k) exempt.

Have CKH devices been recalled?

Yes: 1 product recalls across 1 recall events; the most recent began 2004-08-20.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times